Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX) has a beta value of 1.49 and has seen 26.24 million shares traded in the last trading session. The company, currently valued at $1.65M, closed the last trade at $2.85 per share which meant it lost -$0.2 on the day or -6.56% during that session. The BDRX stock price is -2496.49% off its 52-week high price of $74.00 and 2.46% above the 52-week low of $2.78.

Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX) trade information

Sporting -6.56% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the BDRX stock price touched $2.85 or saw a rise of 35.81%. Year-to-date, Biodexa Pharmaceuticals Plc ADR shares have moved -29.63%, while the 5-day performance has seen it change -3.39%. Over the past 30 days, the shares of Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX) have changed -31.65%.

Biodexa Pharmaceuticals Plc ADR (BDRX) estimates and forecasts

The company’s shares have lost -71.21% over the past 6 months. Revenue growth from the last financial year stood is estimated to be -100.00%.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 86.34% over the past 5 years. Earnings growth for 2025 is a modest 99.87% while over the next 5 years, the company’s earnings are expected to increase by 89.98%.

BDRX Dividends

Biodexa Pharmaceuticals Plc ADR is expected to release its next earnings report in April this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.